calcium Cav2.2 channel blocker (Convergence Pharmaceuticals/Calchan)

N/A

Report date: 2025/03/14 16:24:38
NME

Base Information

Drug Namecalcium Cav2.2 channel blocker (Convergence Pharmaceuticals/Calchan)
Drug Alias Namecalcium Cav2.2 channel blocker (Convergence Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated N-type calcium channel alpha-1B subunit blockers
TargetsVoltage-gated N-type calcium channel alpha-1B subunit
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCalchan Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCalchan Ltd
Inactive CompaniesConvergence Pharmaceuticals Ltd
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A